Goldman Sachs Group Inc I Mab Transaction History

Goldman Sachs Group Inc

$555 Billion
Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in I Mab stock. As of the latest transaction made, Goldman Sachs Group Inc holds 84,941 shares of IMAB stock, worth $127,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,941

Previous 145,195 41.5%

Holding current value

$127,411

Previous $275,000 42.91%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.54 - $2.37 $92,791 - $142,801	-60,254 Reduced 41.5%	84,941 $157,000
Q4 2023 Feb 13, 2024	SELL	$1.21 - $1.9 $116,372 - $182,734	-96,176 Reduced 39.85%	145,195 $275,000
Q3 2023 May 14, 2024	BUY	$1.18 - $3.06 $113,487 - $294,298	96,176 Added 66.24%	241,371 $318,000
Q3 2023 Nov 14, 2023	SELL	$1.18 - $3.06 $62,731 - $162,675	-53,162 Reduced 18.05%	241,371 $318,000
Q2 2023 May 14, 2024	SELL	$2.95 - $3.85 $190,531 - $248,659	-64,587 Reduced 17.98%	294,533 $880,000

Q2 2023 Aug 14, 2023	SELL	$2.95 - $3.85 $190,531 - $248,659	-64,587 Reduced 17.98%	294,533 $880,000
Q1 2023 May 14, 2024	SELL	$3.08 - $7.39 $533,948 - $1.28 Million	-173,360 Reduced 32.56%	359,120 $1.24 Million
Q1 2023 May 11, 2023	SELL	$3.08 - $7.39 $533,948 - $1.28 Million	-173,360 Reduced 32.56%	359,120 $1.24 Million
Q4 2022 May 14, 2024	SELL	$3.22 - $4.86 $1.95 Million - $2.94 Million	-605,858 Reduced 53.22%	532,480 $2.23 Million
Q4 2022 Feb 13, 2023	SELL	$3.22 - $4.86 $1.95 Million - $2.94 Million	-605,858 Reduced 53.22%	532,480 $2.23 Million
Q3 2022 May 14, 2024	BUY	$4.01 - $12.34 $237,163 - $729,824	59,143 Added 5.48%	1,138,338 $4.57 Million
Q3 2022 Nov 10, 2022	BUY	$4.01 - $12.34 $237,163 - $729,824	59,143 Added 5.48%	1,138,338 $4.56 Million
Q2 2022 May 14, 2024	BUY	$8.27 - $18.43 $7.72 Million - $17.2 Million	934,000 Added 643.27%	1,079,195 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$8.27 - $18.43 $2.92 Million - $6.5 Million	352,503 Added 48.51%	1,079,195 $12.2 Million
Q1 2022 May 16, 2022	BUY	$12.54 - $46.93 $4.52 Million - $16.9 Million	360,273 Added 98.32%	726,692 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$45.28 - $74.5 $7.06 Million - $11.6 Million	155,858 Added 74.02%	366,419 $17.4 Million
Q3 2021 Nov 10, 2021	BUY	$57.18 - $84.43 $12 Million - $17.8 Million	210,561 New	210,561 $15.3 Million

Others Institutions Holding IMAB

# of Institutions

Shares Held

16M

Call Options Held

11.9K

Put Options Held

3.5K

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $125M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc I Mab Transaction History